Native Meta creative and exact outbound link observed October 22, 2026. Redirects were followed to the captured public destination. The selection includes GLP-1 care and NAD+ creator messages. The peptide waitlist is a separately sourced page reference. Advertiser claims are source material; activity does not establish performance. No personal, health or payment details were entered.

A dedicated offer page combines pricing presentation, treatment plans, customer stories, care inclusions and the online-care entry. Compare the creative with the destination and explore the other ads sharing this route.
Selected for its design and offer structure. Ad performance isn’t available in this collection.
Chelsea names a problem a lot of viewers will recognize right away, a lifetime of yo-yoing, which is the kind of specific pain the persona's best ads open on. Her maintenance-era framing speaks to people worried about what happens after the first months, which most weight-loss ads skip. The copy then answers the practical questions in plain lines: $99 a month, locked as long as she's with them, clinician, dietitian and coaching included, no membership fees and no insurance needed. Fridays ran several versions of this from October 21, 2026.
The headline asks viewers to take the 2-minute quiz, but the page the ad sends them to opens on a Lock in my price coupon, not a quiz, so the promised first step isn't the first thing they see. The video also states her claims about retraining cravings as plain fact in her words, which is fine as testimony, but there's no on-screen marker that results vary. Point the button text and the page hero at the same first step, and keep a short results-vary line on screen for testimony like this.
A specific personal result stops the scroll and sets up the story.
Naming a long-running, familiar problem makes the viewer see themselves in the story.
Her conviction carries the emotional weight; the claim is hers, as testimony.
The close turns curiosity into a direct instruction and a price.
$99 a month, with the price locked as long as you stay subscribed; clinician, dietitian and coaching included, no membership fees.
The ad lands on the price-lock offer page, a focused landing page. The coupon hero says as low as $99 a month with forever pricing, which matches the copy, and the following block lists drug prices, included clinical care and a qualify-in-two-minutes line. The maintenance story she tells has no obvious home in the captured hero; the customer stories section further down is where a visitor would look for it.
A dedicated Fridays offer page for GLP-1 care that opens on a coupon-style card promising as low as $99 a month with forever pricing, then moves through drug prices, plans, customer stories, the care team and safety information. 12 Fridays ads in the library send people here, mostly creator stories and price-lock statics.
A dashed coupon card announces GLP-1 care as low as $99 a month with forever pricing, a countdown and a Lock in my price button, answering what's the deal.
A Now as Low as $99/mo GLP-1 Weight Loss headline lists semaglutide and tirzepatide prices, included clinical care and a two-minute qualification, answering what exactly do I get for that price.
A before-and-after photo pair with a vial sits beside a rating line that cites reviews and a success-rate figure, answering does anyone like this.
A row of media logos (Bloomberg, Forbes, Healthline, WebMD, Fortune, Fast Company) answers is this a company people have heard of.
Plans and a comparison lay out the options side by side, answering which one should I pick.
Stories from customers answer what was it like for someone like me.
This section shows the care that comes with the plan and the clinicians behind it, answering who's actually looking after me.
The steps to get started answer what happens after I click.
Questions and safety details close the page, answering the remaining what-ifs and the required disclosures.
Read the full breakdown of this page
One of 21 Fridays ads in the Fluid Inspiration Library, captured from the Meta Ad Library on Oct 22, 2026. We record that an ad ran publicly, not how it performed.